Yayınlar & Eserler

Yayın Ağı
Makaleler 67
Tümü (67)
SCI-E, SSCI, AHCI (52)
SCI-E, SSCI, AHCI, ESCI (61)
ESCI (10)
Scopus (64)
TRDizin (17)
Diğer Yayınlar (1)

1. Comment on the Association of Coronary Artery Severity and Late In-Stent Restenosis: An Angiographic Imaging Study

Murat B., MURAT S., GÖRENEK B.
ANGIOLOGY , cilt.76, sa.9, ss.909-910, 2025 (SCI-Expanded) identifier identifier identifier

2. Comparison of Prognostic Value of FIB-4 with FIB-5 in STEMI Patients Undergoing Primary PCI

Murat B., Aydın F., Durmaz F. E., Ozden B., MURAT S.
Bratislava Medical Journal , cilt.126, sa.9, ss.2313-2321, 2025 (SCI-Expanded) identifier

3. TG/HDL-C Ratio as a Superior Diagnostic Biomarker for Coronary Plaque Burden in First-Time Acute Coronary Syndrome

Aydin F., Murat B., MURAT S., Dağhan H.
Diagnostics , cilt.15, sa.17, 2025 (SCI-Expanded) identifier identifier

4. The value of the HFA-PEFF and H2FPEF scores in determining the phenotypes and comorbidity burden in heart failure with preserved ejection fraction

MURAT S., Murat B., Yalvac H. E., Durmaz F. E., Inan D., Celik A., et al.
Clinical Physiology and Functional Imaging , cilt.45, sa.4, 2025 (SCI-Expanded) identifier

5. Positive T wave in lead aVR is associated with left atrial and ventricular function and cardiac outcomes in heart failure patients with preserved ejection fraction

Murat B., MURAT S., Aydın F., DURAL M., Yalvac H. E., Durmaz F. E., et al.
Journal of Electrocardiology , cilt.90, 2025 (SCI-Expanded) identifier identifier

6. Comments on Age-dependent influence of T wave amplitude on short period temporal dispersion in healthy subjects

Murat B., MURAT S., GÖRENEK B.
Journal of Electrocardiology , cilt.90, 2025 (SCI-Expanded) identifier identifier

7. Comments on “can electrocardiographic repolarization predict diabetes incidence: The Atherosclerosis Risk in Communities Study”

Murat B., Beral A., MURAT S.
Journal of Electrocardiology , cilt.90, 2025 (SCI-Expanded) identifier identifier

8. Sol Dal Alan Pacing Tedavisine Ekokardiyografik Yanıtı Göstermede Cornell Product'ın Değeri Using Cornell Product to Predict Echocardiographic Response of Left Bundle Branch Area Pacing

MURAT S., MERT G. Ö., Durmaz F. E., Karakuş E., ÖZKAYA İ., DURAL M.
Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir , cilt.53, sa.3, ss.159-166, 2025 (Scopus) identifier identifier

9. Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED-HEART study

Kocabas U., ERGİN I., Yavuz V., Altin C., Kaplan M., Oztekin G. M. Y., et al.
ESC HEART FAILURE , cilt.12, sa.1, ss.434-446, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

10. The one-minute sit-to-stand test is an alternative to the 6-minute walk test in patients with atrial fibrillation: A cross-sectional study and ROC curve analysis

Ozel C., Ozdemir H. Y., Dural M., Al A., Yalvac H. E., Mert G. O., et al.
International Journal of Cardiology , cilt.419, 2025 (SCI-Expanded) identifier identifier

11. Impact of the Pre-Procedural Pan-Immune Inflammation Value on Long-Term Mortality in Patients With Peripheral Artery Disease Following Endovascular Treatment: A Comparative Study

Murat B., Aydın F., Sener E., Ozden B., Kaya I. C., Heval A., et al.
Angiology , 2025 (SCI-Expanded, Scopus) identifier identifier identifier

12. Noninvasive assessment of disproportionate right to left ventricular filling pressure in patients with heart failure

Güvenç T. S., Asarcıklı L. D., İnan D., MURAT S., Çöllüoğlu İ. T., Bakhshaliyev N., et al.
International Journal of Cardiovascular Imaging , 2025 (SCI-Expanded, Scopus) identifier identifier identifier

13. Incidence and Predictors of Clinical Outcomes in Real-Life Patients With Atrial Fibrillation Treated With Oral Factor Xa Inhibitors: The Follow-Up Results of the ANATOLIA-AF Study

Kocabas U., ERGİN I., Sonmez S. C., Yavuz V., MURAT S., Ozdemir I. H., et al.
CLINICAL CARDIOLOGY , cilt.48, sa.1, 2025 (SCI-Expanded) identifier identifier identifier

14. Reply to the Letter to the Editor: ‘’The Need for a New Description of Red Flags in Cardiac Amyloidosis in Turkish Population’’ Editöre Mektup Yanıtı: Türk Toplumunda Kardiyak Amiloidozda Kırmızı Bayrakların Yeni Bir Tanımına Olan İhtiyaç

MURAT S., Yalvaç H. E., ÇAVUŞOĞLU Y.
Turk Kardiyoloji Dernegi Arsivi , cilt.53, sa.1, ss.82-83, 2025 (ESCI) identifier identifier

15. Associations Between Echocardiographic Right Heart Measurements With Short-Term Prognosis in Heart Failure: A Prospective Study

Dinc Asarcikli L., Inan D., Murat S., Colluoglu I. T., Bakhshaliyev N., Ulutaş Z., et al.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES , cilt.41, sa.10, 2024 (SCI-Expanded) Creative Commons License identifier identifier identifier

16. The relationship between serum sodium variability and survival in heart failure patients: results from TRends-HF

MURAT S., Cavusoglu Y., ŞAHİN A., Colluoglu I. T., Celik A., Yilmaz M. B.
EUROPEAN JOURNAL OF HEART FAILURE , ss.337, 2024 (SCI-Expanded) identifier

17. PrevAleNce and Associated factors of inappropriaTe dosing of direct Oral anticoaguLants In pAtients with Atrial Fibrillation: the ANATOLIA-AF Study

Kocabaş U., ERGİN I., Yavuz V., MURAT S., Özdemir I., Genç Ö., et al.
Cardiovascular Drugs and Therapy , cilt.38, sa.3, ss.581-599, 2024 (SCI-Expanded) identifier identifier identifier

18. The 6-minute walk test and fall risk in patients with heart failure: A cross-sectional study

Yakut Ozdemir H., Bozdemir Ozel C., Dural M., Yalvac H. E., Al A., Murat S., et al.
Heart and Lung , cilt.64, ss.80-85, 2024 (SCI-Expanded) identifier identifier identifier

19. Ticagrelor Induced Cheyne-Stokes Respiration and Asystolic Ventricular Standstill: A Case Report

Murat B., MURAT S., Kivanc E.
Kardiologiia , cilt.64, sa.2, ss.80-84, 2024 (SCI-Expanded) identifier identifier

20. Association of Pan Immune-Inflammation Value with Long Term Outcomes of Acute Decompensated Heart Failure

Murat B., MURAT S., Altinbas M. E., Yalvac H. E., DURMAZ F. E., MERT K. U., et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA , sa.6, 2024 (SCI-Expanded) identifier

21. Burden of comorbidities in heart failure patients in Türkiye

ÇAVUŞOĞLU Y., MURAT S., ŞAHİN A., Çöllüoğlu İ. T., Ural D., YILMAZ M. B., et al.
Turkish Journal of Medical Sciences , cilt.54, sa.7, ss.1478-1487, 2024 (SCI-Expanded) identifier identifier

22. Diagnostic approach to heart failure in Türkiye

Ural D., Asarcikli L. D., Çöllüoğlu İ. T., Şahin A., Çavuşoğlu Y., Yilmaz M. B., et al.
Turkish Journal of Medical Sciences , cilt.54, sa.7, ss.1461-1469, 2024 (SCI-Expanded) identifier identifier

23. Fixed-Dose Antiplatelet Dual Combination in Patients with Coronary Artery Disease in Turkish Population: DAPT-TR Terapia Antiplaquetária Dupla Combinada em Pacientes com Doença Arterial Coronariana em uma População na Turquia: DAPT-TR

Öz A., Toprak K., Aydin E., Saraç İ., Doğduş M., Opan S., et al.
Arquivos Brasileiros de Cardiologia , cilt.121, sa.11, 2024 (SCI-Expanded) identifier identifier

24. Patient Perception, Knowledge and Adaptation in The Management of Heart Failure: A Multicenter, Cross-Sectional, Observational, Questionnaire-Based Study: ADAPTATION HF Kalp Yetersizliğinin Yönetiminde Hasta Algı, Bilgi ve Adaptasyonu: Çok Merkezli, Kesitsel, Gözlemsel, Ankete Dayalı Çalışma: ADAPTATION HF

MURAT S., ÇAVUŞOĞLU Y., YILMAZ M. B., Yıldırımtürk Ö., Ülvan N., Çelik A., et al.
Turk Kardiyoloji Dernegi Arsivi , cilt.52, sa.1, ss.18-26, 2024 (ESCI) Creative Commons License identifier identifier

25. Farklı Kardiyoselektif ß-Blokerler ve Egzersiz Sırasında Abartılı Kan Basıncı Yanıtının Önlenmesi: Retrospektif Bir Kesitsel Çalışma Different Cardio-Selective ß-Blockers and the Prevention of Exaggerated Blood Pressure Response During Exercise: A Retrospective Cross-Sectional Study

MERT G. Ö., ŞENER E., YILMAZ A. S., YETMİŞ F., Çamlı E., DURMAZ F. E., et al.
Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir , cilt.52, sa.1, ss.27-35, 2024 (Scopus) Creative Commons License identifier identifier

26. Medical and advanced heart failure therapies in Türkiye

Nalbantgil S., Demir E., Çelik A., Çöllüoğlu İ. T., Ata N., Yilmaz M. B., et al.
Turkish Journal of Medical Sciences , cilt.54, sa.7, ss.1470-1477, 2024 (SCI-Expanded) identifier identifier

27. Epidemiology of heart failure in Türkiye

Ata N., Çöllüoğlu İ. T., Şahin A., Yilmaz M. B., Nalbantgil S., Birinci Ş., et al.
Turkish Journal of Medical Sciences , cilt.54, sa.7, ss.1447-1454, 2024 (SCI-Expanded) identifier identifier

28. Outcomes of patients with heart failure in Türkiye

ŞAHİN A., YILMAZ M. B., Çelik A., Çöllüoğlu İ. T., Ural D., Asarcikli L. D., et al.
Turkish Journal of Medical Sciences , cilt.54, sa.7, ss.1488-1496, 2024 (SCI-Expanded) identifier identifier

29. Fixed-Dose Antiplatelet Dual Combination in Patients with Coronary Artery Disease in Turkish Population: DAPT-TR

Oz A., Toprak K., Aydin E., Sarac I., Dogdus M., Opan S., et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA , sa.11, 2024 (SCI-Expanded) identifier

30. Association of Pan Immune-Inflammation Value with Long Term Outcomes of Acute Decompensated Heart Failure Associação do Valor Pan-Imune-Inflamatório com Desfechos de Longo Prazo na Insuficiência Cardíaca Agudamente Descompensada

Murat B., MURAT S., Altınbas M. E., Yalvac H. E., DURMAZ F. E., MERT K. U., et al.
Arquivos Brasileiros de Cardiologia , cilt.121, sa.6, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

31. Association between Pfizer-BioNTech mRNA vaccine and myocardial infarction: clinical and angiographic insights

Aydin F., Murat B., MURAT S., Aydin A. H.
CARDIOVASCULAR JOURNAL OF AFRICA , 2023 (SCI-Expanded) identifier identifier

32. Trends in heart failure between 2016 and 2022 in Türkiye (TRends-HF): a nationwide retrospective cohort study of 85 million individuals across entire population of all ages

Celik A., Ural D., Şahin A., Colluoglu I. T., Kanik E. A., Ata N., et al.
The Lancet Regional Health - Europe , cilt.33, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

33. Door to Balloon Time of Non-ST Elevation Myocardial Infarction May be Reconsidered According to Systemic Immune-Inflammation Index

Ozgeyik M., Yildirim O. T., Ozgeyik M. O., Murat B., MURAT S.
Kardiologiia , cilt.63, sa.9, ss.56-62, 2023 (SCI-Expanded) identifier identifier

34. Effect of COVID-19 pandemic on management and the in-hospital outcome of ST segment elevation myocardial infarction

Murat B., MURAT S., Kivanc E., Dizman R.
KUWAIT MEDICAL JOURNAL , cilt.55, sa.3, ss.224-229, 2023 (SCI-Expanded) identifier identifier

35. Is atrial fibrillation the same clinical entity in all cardiac settings?

Murat S., Murat B., Görenek B.
Acta Cardiologica , cilt.78, sa.6, ss.748, 2023 (SCI-Expanded) identifier identifier identifier

36. Left atrial function as a predictor of stroke or systemic embolism: Beyond the CHA(2) DS(2) -VASc score.

Murat B., Murat S., Gorenek B.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc , cilt.28, sa.4, 2023 (SCI-Expanded) identifier identifier identifier

37. Sol Dal Bloğu İlişkili Kardiyomiyopati

MURAT S., ÇAVUŞOĞLU Y.
Türk Kardiyoloji Derneği Arşivi , cilt.51, sa.4, ss.274-282, 2023 (ESCI) Creative Commons License identifier identifier identifier identifier

38. Hand-held echocardiography during complex electrophysiologic procedures

MURAT S., ULUS T., YILMAZ A. S., YALVAÇ H. E., ÇAMLI E., DURAL M.
Journal of Cardiovascular and Thoracic Research , cilt.15, sa.2, ss.80-85, 2023 (ESCI) Creative Commons License identifier identifier identifier

39. Atriyal fibrilasyon hastalarında gerçek yaşam antikoagülan tedavi tercihlerinin değerlendirilmesi: Çok merkezli ROTA Çalışması verileri Real-World Evaluation of Anticoagulant Treatment Patterns in Patients with Atrial Fibrillation: Data from Multicenter ROTA Study

Kocabaş U., ERGİN I., Yavuz V., MURAT S., Özdemir I., Genç Ö., et al.
Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir , cilt.51, sa.2, ss.88-96, 2023 (ESCI) Creative Commons License identifier identifier identifier identifier

40. Left atrial structure and function: association with blood pressure variability in pregnant women.

Murat S., Velipasaoglu M., Murat B., Al A., Cicek S., Cavusoglu Y.
Blood pressure monitoring , cilt.28, sa.1, ss.42-46, 2023 (SCI-Expanded) identifier identifier identifier

41. Predictors of left atrial thrombosis in atrial fibrillation patients treated with direct oral anticoagulants

MURAT S., Murat B., GÖRENEK B.
ACTA CARDIOLOGICA , cilt.78, sa.3, ss.371, 2023 (SCI-Expanded) identifier identifier identifier

42. RELATIONSHIP BETWEEN LEFT ATRIAL FUNCTIONS AND AMBULATORY BLOOD PRESSURE VARIABILITY IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION

Murat S., Murat B., Yalvac H. E., Dural M., Mert K. U., Cavusoglu Y.
KARDIOLOGIYA , cilt.63, sa.1, ss.48-53, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

43. Comparison of pan-immune-inflammation value with other inflammation markers of long-term survival after ST-segment elevation myocardial infarction

Murat B., Murat S., Ozgeyik M., Bilgin M.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , cilt.53, sa.1, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

44. Comparison of long-term outcome of patients with ST-segment elevation myocardial infarction between pre-COVID-19 and COVID-19 era.

Kiris T., Avci E., Ekin T., Akgün D. E., Tiryaki M., Yidirim A., et al.
European journal of clinical investigation , cilt.52, sa.10, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

45. The relationship between the clinical characteristics of patients with heart failure and preserved ejection fraction and systemic immune inflammation index

MURAT S., Murat B., Yalvac H. E., DURAL M., Cavusoglu Y.
EUROPEAN JOURNAL OF HEART FAILURE , cilt.24, ss.80, 2022 (SCI-Expanded) identifier

46. Comments on impact of obesity on acute complications of catheter ablation for cardiac arrhythmia

Murat B., Murat S., Gorenek B.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY , cilt.33, sa.6, ss.1344, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

47. Assessment of clinical characteristics of cardiac amyloidosis as a potential underlying etiology in patients diagnosed with heart failure with preserved ejection fraction

Murat S., Cavusoglu Y., Yalvac H. E., Sivrikoz İ., Kocagil S.
KARDIOLOGIA POLSKA , cilt.80, sa.6, ss.672-678, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

48. Peritoneal Dialysis in Advanced Heart Failure Patients with Chronic Severe Congestion Resistant to Optimal Pharmacological Treatment.

Murat S., Özkurt S., Çavuşoğlu Y.
Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir , cilt.50, sa.3, ss.217-224, 2022 (ESCI) identifier identifier

49. Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry).

Kiris T., Avci E., Ekin T., Akgün D. E., Tiryaki M., Yidirim A., et al.
Journal of thrombosis and thrombolysis , cilt.53, sa.2, ss.321-334, 2022 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

50. Clinical characteristics and in-hospital outcomes of COVID-19 patients with history of heart failure: a propensity score-matched study.

Murat B., Murat S., Mert K. U., Bilgin M., Cavusoglu Y.
Acta cardiologica , cilt.77, sa.1, ss.37-44, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

51. Fragmented QRS formation in nonhypertensive acromegaly patients

DURAL M., YORULMAZ G., MERT K. U., MURAT S.
Turkish Journal of Medical Sciences , cilt.52, sa.4, ss.1413-1414, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier identifier

52. Prognostic value of D-dimer/fibrinogen ratio on in-hospital outcomes of patients with heart failure and COVID-19.

Murat S., Murat B., Dural M., Mert G. Ö., Cavusoglu Y.
Biomarkers in medicine , cilt.15, sa.16, ss.1519-1528, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

53. Gender differences in clinical characteristics and in-hospital and one-year outcomes of young patients with ST-segment elevation myocardial infarction under the age of 40

Murat B., Kivanc E., Dizman R., Mert G. Ö., MURAT S.
JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH , cilt.13, sa.2, ss.116-124, 2021 (ESCI) identifier identifier identifier

54. Comments on the value of ECG changes in risk stratification of COVID-19 patients

MURAT S., Babayigit E., GÖRENEK B.
Annals of Noninvasive Electrocardiology , cilt.26, 2021 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

55. Assesment of Cerebral Blood Flow Velocities with Transcranial Doppler Ultrasonography in Heart Failure Patients with Reduced Ejection Fraction.

Babayiğit E., Murat S., Mert K. U., Çavuşoğlu Y.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association , cilt.30, sa.5, ss.105706, 2021 (SCI-Expanded) identifier identifier identifier

56. Hyperkalemia in chronic heart failure with renal dysfunction or diabetes mellitus: Results from the TREAT HF study.

Murat S., Kaya H., Çavuşoğlu Y., Yılmaz M. B.
Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir , cilt.49, ss.198-205, 2021 (ESCI) Sürdürülebilir Kalkınma identifier identifier identifier identifier

57. Comments on development and validation of home delivery for ambulatory ECG monitoring.

Murat B., Murat S., Gorenek B.
Journal of electrocardiology , cilt.65, ss.121, 2021 (SCI-Expanded) identifier identifier identifier

58. The impact of hydroxychloroquine and azithromycin on the corrected qt interval in patients with the novel Coronavirus disease 2019

Murat B., Akgun H., Akarsu M., Ozmen A., MURAT S.
Revista da Associacao Medica Brasileira , cilt.67, sa.7, ss.979-984, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

59. Assessment of fragmented QRS formation and its relationship with left ventricular hypertrophy in nonhypertensive acromegaly patients

Dural M., Yorulmaz G., Alagüney E. S., Mert K. U., Çamli E., Kalkan A. T., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.5, ss.2437-2444, 2021 (SCI-Expanded) identifier identifier identifier identifier

60. Comments on efficacy and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and diabetes mellitus.

Murat S., Murat B., Gorenek B.
Acta cardiologica , cilt.76, sa.9, ss.1041, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

61. Changing in Gender Differences in Heart Rate Variability in Healthy Human According to Age: Cross-Sectional Study

MERT G. Ö., BABAYİĞİT E., MURAT S., DURAL M., MERT K. U.
Turkiye Klinikleri Cardiovascular Sciences , cilt.33, 2021 (Scopus) Sürdürülebilir Kalkınma identifier identifier

62. Wild type transthyretin cardiac amiloidozis as a rare and overlooked underlying etiology in a patient with heart failure with preserved ejection fraction and left ventricular hypertrophy Sol ventrikül hipertrofisi ve korunmuş ejeksiyon fraksiyonlu kalp yetersizliğinin sıklıkla atlanan ve nadir bir nedeni olan doğal (wild type) transtiretine bağlı kardiyak amiloidoz olgusu

Murat S., Çavuşoğlu Y., Ak Sivrikoz İ.
Turk Kardiyoloji Dernegi Arsivi , cilt.49, sa.7, ss.579-584, 2021 (ESCI) identifier identifier identifier identifier

63. The association of exaggerated hypertensive response to exercise and beta-blockers use in hypertensives.

Mert K. U., ŞENER E., Yilmaz A. S., Mert G. Ö., Yetmis F., Dural M., et al.
Clinical and experimental hypertension (New York, N.Y. : 1993) , cilt.42, sa.8, ss.707-713, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

64. Frequency of coronary artery anomalies and relationship between coronary artery with anomalous origin and myocardial bridge

MURAT B., MURAT S.
Medicine Science , cilt.9, sa.3, ss.595-599, 2020 (Hakemli Dergi)

65. Klinik Uygulamada Sakubitril/Valsartan

MURAT S.
UPDATES İN CARDİOLOGY , cilt.3, sa.2, ss.115-117, 2020 (Hakemli Dergi)

66. Treatment of the left and the right coronary arteries’xx ostial lesions by stenting in a patient with immune thrombocytopenic purpura

MURAT B., MURAT S.
Medicine Science , cilt.8, sa.2, ss.445-448, 2019 (Hakemli Dergi)

67. Hyponatremia is associated with occurrence of atrial fibrillation in outpatients with heart failure and reduced ejection fraction

Çavuşoğlu Y., Kaya H., Eraslan S., Yılmaz M. B.
HELLENIC JOURNAL OF CARDIOLOGY , cilt.60, sa.2, ss.117-121, 2019 (SCI-Expanded) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 79

1. Left atrio-ventricular global longitudinal strain as a predictor of mortality in heart failure with preserved ejection fraction

Murat S., Durmaz F. E., Akdoğan A. T., Yalvaç H. E., Murat B., Çavuşoğlu Y.
40th NATIONAL CARDIOLOGY CONGRESS, Antalya, Türkiye, 6 - 10 Kasım 2024, ss.47-48, (Tam Metin Bildiri) Creative Commons License

2. Fibrosis-4 index may predict long-term mortality in patients admitted for acute decompensated heart failure

MURAT B., MURAT S., DURMAZ F. E., DURAL M., ALTINBAŞ M. E., ÇAVUŞOĞLU Y.
ESC Heart Failure Congress 2024 Lizbon, 11 – 14 May 2024, lizbon, Portekiz, 11 Mayıs 2024, (Tam Metin Bildiri)

3. The relationship between serum sodium variability and survival in heart failure patients: Results from TRends-HF

MURAT S., ÇAVUŞOĞLU Y., ŞAHİN A., ÇÖLLÜOĞLU İ. T., ÇELİK A., YILMAZ M. B.
ESC Heart Failure Congress 2024 Lizbon, 11 – 14 May 2024, lizbon, Portekiz, 11 Mayıs 2024, (Tam Metin Bildiri)

4. The value of scoring systems in terms of phenogroups in the diagnosis of heart failure with preserved ejection fraction

MURAT S., MURAT B., YALVAÇ H. E., DURMAZ F. E., İNAN D., ÇELİK A., et al.
ESC Heart Failure Congress 2024 Lizbon, 11 – 14 May 2024, lizbon, Portekiz, 11 Mayıs 2024, (Tam Metin Bildiri)

5. Hyponatremia is highly prevalent and associated with worse clinical outcomes in HF population in Turkiye: results from TRends-HF

MURAT S., ÇAVUŞOĞLU Y., ŞAHİN A., ÇÖLLÜOĞLU İ. T., ÇELİK A., YILMAZ M. B.
ESC Heart Failure Congress 2024 Lizbon, 11 – 14 May 2024, lizbon, Portekiz, 11 Mayıs 2024, (Tam Metin Bildiri)

6. The relationship between anemia and echocardiographic features and all-cause death in patients with heart failure with preserved ejection fraction

MURAT B., MURAT S., DURMAZ F. E., OKUMUŞ R., ÇAVUŞOĞLU Y.
ESC Heart Failure Congress 2024 Lizbon, 11 – 14 May 2024, lizbon, Portekiz, 11 Mayıs 2024, (Tam Metin Bildiri)

7. A case of transthyretin cardiac amyloidosis with p.VAL114Ala mutation manifested by heart failure, right bundle branch block and bilateral carpal tunnel syndrome

MURAT S., AK SİVRİKOZ İ., KOCAGİL S., OKUMUŞ R., ÇAVUŞOĞLU Y.
ESC Heart Failure Congress 2024 Lizbon, 11 – 14 May 2024, lizbon, Portekiz, 11 Mayıs 2024, (Tam Metin Bildiri)

8. Whıch Scorıng System is Better at Predıctıng in-Hospıtal Mortalıty in Heart Faılure Exacerbatıon

ÇANAKÇI M. E., ÇETİN M., ACAR N., BALOĞLU KAYA F., ÖZAKIN E., KARAKILIÇ M. E., et al.
9th Eurasian Congress on Emergency Medicine& TATKON"100 Anniversary" National Congress & 2nd Ultrasonography Symposium in Emergency and Critical Care Patient, Antalya, Türkiye, 9 - 12 Kasım 2023, (Tam Metin Bildiri)

9. Cardiomyopathies

MURAT S.
19th International Congress of Update in Cardiology and Cardiovascular surgery, İstanbul, Türkiye, 04 Kasım 2023, (Tam Metin Bildiri)

10. Gastrointestinal bulgularla seyreden mutant transtiretine bağlı amiloidoz Nadir bir amiloidoz olgusu.2. Ulusal KY Toplantısı 2-3 haziran İstanbul Bildiri Özetleri Turk Kardiyol Dern Ars 2023;51(Suppl 1):1-37. DOI: 10.5543/tkda.2023.S1

MURAT S., YALVAÇ H. E., KOCAGİL S., AK SİVRİKOZ İ., ÜSKÜDAR TEKE H., ÇAVUŞOĞLU Y.
. Ulusal KY Toplantısı 2-3 haziran İstanbul, istsnbul, Türkiye, 02 Haziran 2023, (Tam Metin Bildiri)

11. Association between electrocardiographic diastolic index and left atrial dysfunction in heart failure with preserved ejection fraction Heart Failure 2023 Prague, 20 – 23 May 2023

MURAT S., YALVAÇ H. E., OKUMUŞ R., MURAT B., ÇAVUŞOĞLU Y.
ESC Heart Failure Congress 2023 Prague, 20 – 23 May 2023, prag, Çek Cumhuriyeti, 20 Mayıs 2023, (Tam Metin Bildiri)

12. TTR Amiloidoz Kırmızı Bayrak Semptomlar Nelerdir? Kime Ne Zaman İleri İnceleme?

MURAT S.
Ulusal KY Toplantısı 2-3 haziran İstanbul, İstanbul, Türkiye, 02 Haziran 2023, (Tam Metin Bildiri)

13. Left atrial strain predicts one-year composite clinical outcome in patients with heart failure with preserved ejection fraction.

MURAT S., YALVAÇ H. E., MURAT B., ÇAVUŞOĞLU Y.
ESC Heart Failure Congress 2023 Prague, 20 – 23 May 2023, prag, Çek Cumhuriyeti, 20 Mayıs 2023, (Tam Metin Bildiri)

14. Left atrial strain predicts one-year composite clinical outcome in patients with heart failure with preserved ejection fraction. Heart Failure 2023 Prague 20-23 May 2023

MURAT S., YALVAÇ H. E., MURAT B., ÇAVUŞOĞLU Y.
ESC Heart Failure Congress 2023 Prague, 20 – 23 May 2023, prag, Çek Cumhuriyeti, 20 Mayıs 2023, (Tam Metin Bildiri)

15. Koroner anjiografi sonrası kontrast nefropati gelişen hastalarda oksidatif stres indeksi ve 8-hidroksi 2'-deoksi guanozin düzeyi ile DNA hasar analizi

Demirkıran Ö., Kocatürk E., Demiryürek B., Murat S., Tezcan N., Bal C., et al.
25.Ulusal Hipertansiyon ve Böbrek Hastalıkları Kongresi, Muğla, Türkiye, 09 Mayıs 2023, (Özet Bildiri)

16. HAND-HELD ECHOCARDIOGRAPHY FOR ASSESSMENT OF COMPLICATIONS DURINGCOMPLEX ELECTROPHYSIOLOGIC PROCEDURES

Ulus T., Murat S., Yılmaz A. S., Yalvaç H. E., Çamlı E., Dural M.
18th International Congress of Update in Cardiology and Cardiovascular Surgery, Antalya, Türkiye, 1 - 04 Aralık 2022, (Tam Metin Bildiri) Creative Commons License

17. Serum albumin to creatinine ratio as predictor for long-term mortality in patients with acute heart failure

Murat S., Altınbaş M. E., Yalvaç H. E., Durmaz F. E., Murat B., Çavuşoğlu Y.
38th Turkish Cardiology Congress on 10-13 November 2022, Antalya, Türkiye, 10 Kasım 2022, ss.45-46, (Tam Metin Bildiri) Creative Commons License

18. Door to Balloon Time of Non-STEMI May be Reconsidered according to Systemic Immune-Inflammation Index

ÖZGEYİK M., TURGAY YILDIRIM Ö., MURAT B., MURAT S.
38. Ulusal Kardiyoloji Kongresi 10-13 Kasım 2022, antalya, Antalya, Türkiye, 10 Kasım 2022, (Tam Metin Bildiri)

19. Arnis in HFPEF and HFMREF?

MURAT S.
18th International Congress of Update in Cardiology and Cardiovascular Surgery, Antalya, Türkiye, 01 Aralık 2022, (Tam Metin Bildiri)

20. EVALUATION OF ROLE AND EFFECT OF PERFUSION INDEX MEASUREMENT IN MANAGEMENT OF PATIENTS DIAGNOSED WITH STEMI IN THE EMERGENCY DEPARTMENT; PROSPECTIVE, OBSERVATIONAL STUDY

Ahmadzai O., Baloğlu Kaya F., Özakın E., Murat S., Acar N., Karakılıç M. E., et al.
8th Eurasian Congress of Emergency Medicine & 18th Emergency Medicine Congress of Turkey & 17th World Interactive Network Focused on Critical Ultrasound Congress, Antalya, Türkiye, 1 - 04 Aralık 2022, ss.215-219, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

21. Hand-Held Echocardiography for Assessment of Complications During Complex Electrophysiological Procedures

Ulus T., Murat S., Şener E., Yalvaç H. E., Çamlı E., Dural M.
18th International Congress of Update in Cardiology and Cardiovascular Surgery (Online Congress), Antalya, Türkiye, 1 - 04 Aralık 2022, cilt.10, ss.151-152, (Tam Metin Bildiri) Creative Commons License

22. The Correlation between Left Atrial phasic function and N-Terminal Pro-BNP levels in Heart Failure with a Preserved Ejection Fraction

Murat S., Murat B., Yalvaç H. E., Dural M., Çavuşoğlu Y.
The International Academy of Young Cardiologists 2022 congress, Girne, Kıbrıs (Kktc), 16 Eylül 2022, ss.59, (Tam Metin Bildiri) Creative Commons License

23. İNTRAKARDİYAK KAVERNÖZ HEMANJİOM; OLGU SUNUMU

Şeker N. S., Tunç H., Dernek S., Murat S.
31. ULUSAL PATOLOJİ KONGRESİ, Aydın, Türkiye, 26 - 30 Ekim 2022, ss.1-2, (Özet Bildiri) Creative Commons License

24. The Relationship between Heart Failure and Systemic Immune Inflammation Index in the ED

Çanakçı M. E., Murat S., Dalaman E. M., Acar N., Çavuşoğlu Y.
XIth Mediterranean Emergency Medicine Congress (MEMC) Malta 21-24 September 2022, Fontana, Malta, 21 Eylül 2022, ss.1-3, (Tam Metin Bildiri) Creative Commons License

25. The relationship between the clinical characteristics of patients with heart failure and preserved ejection fraction and systemic immune inflammation index

MURAT S., MURAT B., YALVAÇ H. E., DURAL M., ÇAVUŞOĞLU Y.
Heart Failure Congress, madrid, Spain, 21–24 May 2022, 21 Mayıs 2022, (Tam Metin Bildiri)

26. Blood pressure variability and left atrial abnormalities in patients with heart failure and preserved ejection fraction

MURAT S., YALVAÇ H. E., MURAT B., MERT K. U., ÇAVUŞOĞLU Y.
Heart Failure Congress, madrid, Spain, 21–24 May 2022, 21 Mayıs 2022, (Tam Metin Bildiri)

27. Korunmuş ejeksiyon fraksiyonlu kalp yetersizliği olgularında aneminin klinik, demografik ve ekokardiyografik özelliklerle ilişkisi

Murat S., Yalvaç H. E., Murat B., Dural M., Çavuşoğlu Y.
Ulusal Kalp Yetersizliği Toplantısı 27-28 Mayıs 2022, İstanbul, Türkiye, İstanbul, Türkiye, 27 Mayıs 2022, ss.1-2, (Tam Metin Bildiri) Creative Commons License identifier

28. BNT162b2 SARS-CoV-2 aşısı sonrası gelişen de novo akut kalp yetersizliği olgusu

Murat S., Yetmiş F., Yıldırımtürk Ö., Aka S., Çavuşoğlu Y.
Ulusal Kalp Yetersizliği Toplantısı 27-28 Mayıs 2022, İstanbul, Türkiye, İstanbul, Türkiye, 27 Mayıs 2022, ss.11-13, (Tam Metin Bildiri) Creative Commons License

29. Value of Age, Creatinine, and Ejection Fraction (ACEF Score) for Predicting Long-TermSurvival in Patients with Heart Failure

Murat S., Altınbaş M. E., Murat B., Dural M., Yalvaç H. E., Durmaz F. E., et al.
1. endokrin kardiyovasküler renal hastalıklar ve aciller kongresi, Girne, Kıbrıs (Kktc), 02 Haziran 2022, ss.52-54, (Tam Metin Bildiri) Creative Commons License

30. F-18 FDG PET/BT’de Sağ Ventriküler Kaviteyi Oblitere Eden Kitle: Primeri Bilinmeyen Bir Tümörün Kardiyak Metastazı

AK SİVRİKOZ İ., AYDIN N., MURAT S., DEVECİ H., ÇELEN A., ATEŞ M.
34. ULUSAL NÜKLEER TIP KONGRESİ, 27 Mart 2022, cilt.8, (Tam Metin Bildiri)

31. Differences in clinical characteristics and outcome of patients admitted to emergency department with de novo heart failure compared to chronic decompensated heart failure

ÇATAL E., ACAR N., ÇANAKÇI M. E., MURAT S., ÇAVUŞOĞLU Y.
37. Uluslararası Katılımlı Türk Kardiyoloji Kongresi, 18 Kasım 2021, (Tam Metin Bildiri)

32. Clinical characteristics and short-term clinical outcomes in patients with acute heart failure and anemia who admitted to the emergency department

MURAT S., ÇANAKÇI M. E., ACAR N., ÇAVUŞOĞLU Y.
37. Uluslararası Katılımlı Türk Kardiyoloji Kongresi, 18 Kasım 2021, (Tam Metin Bildiri)

33. Left atrial abnormalities in patients with heart failure and preserved ejection fraction who have transthyretin cardiac amyloidosis

MURAT S., YALVAÇ H. E., AK SİVRİKOZ İ., ÇAVUŞOĞLU Y.
37. Uluslararası Katılımlı Türk Kardiyoloji Kongresi, 18 Kasım 2021, (Tam Metin Bildiri)

34. RELATIONSHIP OF ADMISSION HEART RATE AND BLOOD PRESSURE ON CLINICAL OUTCOMES IN YOUNG PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION UNDER THE AGE OF 40

MURAT S., MURAT B., ÇANAKÇI M. E.
7th Eurasian Congress on Emergency Medicine & 17th Turkish Congress on Emergency Medicine, Antalya, Türkiye, 25 - 28 Kasım 2021, ss.214, (Özet Bildiri)

35. Non-Invasive Ventilation in Acute Heart Failure: A Prospective Observational Study

Acar N., Çanakçı M. E., Murat S., Çavuşoğlu Y.
7th Eurasian Congress on Emergency Medicine & 17th Turkish Congress on Emergency Medicine, Antalya, Türkiye, 25 - 28 Kasım 2021, ss.406-407, (Tam Metin Bildiri) Creative Commons License

36. Prognostic value of systemic immune-inflammation index in hospitalized COVID-19 patients with coronary artery disease

MURAT S., MURAT B., MERT K. U.
37. Uluslararası Katılımlı Türk Kardiyoloji Kongresi, 18 - 21 Kasım 2021, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

37. THE ONSET OF SYMPTOMS IN MYOCARDIAL BRIDGING: DESTRUCTION OR ATHEROSCLEROSIS?

MERT G. Ö., OVALI C., AYDIN N., MURAT S., MERT K. U., DURAL M.
17th International Congress of Update in Cardiology and Cardiovascular Surgery, 5 - 07 Kasım 2021, (Tam Metin Bildiri)

38. Clinical features and short-term outcomes among acute heart failure emergency department patients by preserved vs. reduced ejection fraction

Çanakçı M. E., Murat S., Acar N., Çavuşoğlu Y.
1st University of Health Sciences International Emergency Medicine Congress, Muğla, Türkiye, 28 - 31 Ekim 2021, ss.308, (Tam Metin Bildiri) Creative Commons License

39. Predictors of length of stay in heart failure patients hospitalized with COVID-19

MURAT B., MURAT S., ÇAVUŞOĞLU Y.
37. Uluslararası Katılımlı Türk Kardiyoloji Kongresi, Antalya, Türkiye, 18 Kasım 2021, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

40. The prevalence of hyperkalemia in patients with acute heart failure admitted to emergency department and its relationship with in-hospital outcomes

ÇANAKÇI M. E., MURAT S., ACAR N., ÇAVUŞOĞLU Y.
37. Uluslararası Katılımlı Türk Kardiyoloji Kongresi, Antalya, Türkiye, 18 Kasım 2021, (Tam Metin Bildiri)

41. Hypoalbuminemia is associated with poor in-hospital clinical outcomes in HF patients hospitalized with COVID-19

MURAT B., MURAT S., DURAL M., ÇAVUŞOĞLU Y.
17 th International Congress of Update in Cardiology and Cardiovascular Surgery, Türkiye, 5 - 07 Kasım 2021, cilt.9, ss.69-70, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

42. Echocardiographic follow-up in breast cancer

MURAT S.
17th International Congress of Update in Cardiology and Cardiovascular Surgery, 05 Kasım 2021, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

43. Latest RCT’s In HF: Messages For My Practice

MURAT S.
17th International Congress of Update in Cardiology and Cardiovascular Surgery, 05 Kasım 2021, (Tam Metin Bildiri)

44. Concordance between quantitative and semi-quantitative analysis of Tc-99m-pyrophosphate scintigraphy for the diagnosis of transthyretin cardiac amyloidosis in patients with HFpEF

MURAT S., YALVAÇ H. E., MERT G. Ö., AK SİVRİKOZ İ., ÇAVUŞOĞLU Y.
ESC Congress 2021, Fransa, 27 - 30 Ağustos 2021, cilt.42, ss.854-855, (Tam Metin Bildiri) Creative Commons License

45. Prevalence of transthyretin cardiac amyloidosis with 99mTc-pyrophosphate (99mTc-PYP) cardiac scintigraphy in patients with heart failure and preserved ejection fraction

Çavuşoğlu Y., Murat S., Ak Sivrikoz İ., Yalvaç H. E.
Heart Failure 2021 Online Congress, 29 Haziran - 01 Temmuz 2021, ss.95, (Özet Bildiri) Creative Commons License

46. Reflection of the new HFA-PEFF scoring system into clinical practice as compared to HFpEF diagnostic criteria of the ESC-HFA 2016 heart failure guidelines

Murat S., Çavuşoğlu Y., Yalvaç H. E.
Heart Failure 2021 Online Congress, 29 Haziran - 01 Temmuz 2021, ss.29, (Özet Bildiri) Creative Commons License

47. Presence of atrial fibrillation prolongs hospital stay in heart failure patients hospitalized with covid-19

Murat B., Murat S., Mert K. U., Çavuşoğlu Y.
Heart Failure 2021 Online Congress, 29 Haziran - 01 Temmuz 2021, ss.5, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

48. Interaction of Phenyramidol HCl and Warfarin: A Case SeriesReport

MURAT B., KIVANÇ E., DİZMAN R., MURAT S.
ISTH 2021 Congress, 17 Temmuz 2021, (Tam Metin Bildiri)

49. Akut Koroner Sendrom Tablosunda Hastane İçi Dönemde Aritmi Sıklığı Üzerine Cinsiyetin Etkisi

Murat B., Murat S.
20th International Eastern Mediterranean Family Medicine Congress, 20 - 23 Mayıs 2021, ss.474-480, (Tam Metin Bildiri) Creative Commons License

50. The impact of hydroxychloroquine and azithromycin on the corrected qt interval in patients with the novel coronavirus disease 2019

Murat B., Murat S.
EHRA, 23 - 25 Nisan 2021, cilt.23, sa.3, ss.22, (Tam Metin Bildiri) Creative Commons License Sürdürülebilir Kalkınma

51. Presence of Chronic Kidney Disease Worsens Clinical Outcomes in Hf Patients Hospitalized With Covıd-19

Murat B., Murat S.
6. INTERNATIONAL HIPPOCRATES CONGRESS ON MEDİCAL AND HEALTH SCIENCES, Ankara, Türkiye, 30 Nisan - 01 Mayıs 2021, sa.1, ss.364-365, (Tam Metin Bildiri) Creative Commons License Sürdürülebilir Kalkınma

52. Dekstrokardi ve situs inversuslu bir hastada ayna hayali görüntüsü kullanılarak aynı seansta atriyal fibrilasyon ve atriyal flutter ablasyonu

ULUS T., DURAL M., ŞENER E., AL A., MERT K. U., MURAT S., et al.
Uluslararası Katılımlı Aritmi Toplantısı, Online, Türkiye, 18 - 20 Aralık 2020, (Tam Metin Bildiri)

53. Atriyal septal defekt kapama cihazının malpozisyonuna bağlı geç dönem trombüs gelişimi

MURAT S., BEKTAŞ M., MERT G. Ö., MERT K. U.
36. Uluslararası Katılımlı Türk Kardiyoloji Kongresi, 3 - 06 Aralık 2020, (Özet Bildiri)

54. Smoking Status was Associated with Blood Pressure Increase during Exercise in Patients with Hypertension

MERT K. U., MERT G. Ö., MURAT S.
36. Uluslararası Katılımlı Türk Kardiyoloji Kongresi, 3 - 06 Aralık 2020, (Özet Bildiri)

55. Association of myocardial bridge with coronary artery aneurysm and ectasia

BEKTAŞ M., MURAT S.
36. uluslararası katılımlı Türk kardiyoloji kongresi, 3 - 06 Aralık 2020, (Tam Metin Bildiri)

56. Atrial fibrillation and atrial flutter ablation using mirror image in a patient with dextrocardia with situs inversus

MURAT S.
RARE CARDIOVASCULAR DISEASE, Ukrayna, 26 - 28 Kasım 2020, (Tam Metin Bildiri)

57. A CASE REPORT LEFT VENTRICULAR TRUE ANEURYSM AND PERICARDIAL EFFUSIONFOLLOWING MYOCARDIAL INFARCTION

MURAT S., ULUS T., OVALI C., DURAL M.
16th International Update in Cardiology and Cardiovascular Surgery (UCCVS) Congress, Türkiye, 30 Ekim - 01 Kasım 2020, (Tam Metin Bildiri)

58. Treatment of the left and the right coronary arteries’xx ostial lesions by stenting in a patientwith Immune Thrombocytopenic Purpura

Murat B., Murat S.
International Young Academy of Cardiology E-Congress 2020, 16 - 20 Eylül 2020, (Tam Metin Bildiri) Creative Commons License

59. Prevalence of hyperkalemia in patients with chronic heart failure in real life clinical practice: Results from TREAT HF Study

ÇAVUŞOĞLU Y., KAYA H., MURAT S., YILMAZ M. B.
Heart failure 2020, European Journal of Heart Failure, 23 - 26 Mayıs 2020, cilt.22, ss.336, (Tam Metin Bildiri) identifier identifier

60. Potantial clinical application of potassium binders in patients with chronic heart failure in real life clinical practice: results from TREAT HF study

ÇAVUŞOĞLU Y., KAYA H., MURAT S., YILMAZ M. B.
ESC Congress 2020, European Heart Journal, 29 Ağustos - 01 Eylül 2020, cilt.41, (Özet Bildiri)

61. Hyperkalemia in heart failure patients with renal dysfunction in real life clinical practice: Results from TREAT HF study

ÇAVUŞOĞLU Y., KAYA H., MURAT S., YILMAZ M. B.
Heart Failure 2020 – HFA Discoveries Virtual Congress, European Journal of Heart Failure, 15 - 19 Haziran 2020, cilt.22, ss.184, (Özet Bildiri)

62. Immunoadsorption therapy in refractory heart failure patients with idiopathic dilated cardiomyopathy: a potential therapeutic option

ÇAVUŞOĞLU Y., Tahmazov S., AKAY O. M., ERASLAN S.
ESC Congress 2018, Munich, Almanya, 25 - 29 Ağustos 2018, cilt.39, (Özet Bildiri)

63. Higher natriuretic peptide levels is associated with higher hs-cTnT, CA-125, hsCRP and lower eGFR, hemoglobin and sodium levels in patients with acute decompensated heart failure.

ÇAVUŞOĞLU Y., Altınbaş M., ERASLAN S.
Heart Failure 2018, Viyana, Avusturya, 26 - 29 Mayıs 2018, cilt.20, ss.5-638, (Özet Bildiri) identifier identifier

64. High sensitive CRP levels is associated with clinical markers of more severe disease in patients with decompensated heart failure.

ÇAVUŞOĞLU Y., Altınbaş M., MUTLU F., ERASLAN S.
33. Uluslar arası Katılımlı Türk Kardiyoloji Kongresi, Anatol J Cardiol, Antalya, Türkiye, 5 - 08 Ekim 2017, cilt.18, ss.79, (Özet Bildiri)

65. Anemia in heart failure is associated with higher CA 125, NT-proBNP and hsCRP levels

Altınbaş M., ÇAVUŞOĞLU Y., MUTLU F., BABAYİĞİT E., İsgendarov K., ERASLAN S.
Heart Failure 2017, European Journal of Heart Failure, Paris, Fransa, 29 Nisan - 02 Mayıs 2017, cilt.19, ss.448, (Özet Bildiri)

66. Chronic kidney disease in heart failure is associated with higher CA 125 and hsCRP levels

ÇAVUŞOĞLU Y., Altınbaş M., MUTLU F., ERASLAN S., İsgendarov K., BABAYİĞİT E.
Heart Failure 2017, European Journal of Heart Failure, Paris, Fransa, 29 Nisan - 02 Mayıs 2017, cilt.19, ss.567, (Özet Bildiri)

67. Atrial fibrillation is more prevalent in heart failure patients with hyponatremia: results from treat HF

ÇAVUŞOĞLU Y., KAYA H., eraslan S.
Heart failure 2016,European Heart Journal ( 2016 ), Florence, İtalya, 21 - 24 Mayıs 2016, cilt.37, ss.535-536, (Özet Bildiri)

68. Hyponatremia increases significantly across worse NYHA functional class categories in chronic heart failure patients with reduced ejection fraction: results from TREAT HF

ÇAVUŞOĞLU Y., MURAT S., KAYA H.
Heart failure 2016,European Journal of Heart Failure, Florence, İtalya, 21 - 24 Mayıs 2016, cilt.18, ss.197, (Özet Bildiri)

69. Blood glucose levels increase significantly across higher NYHA functional class categories in patients with chronic heart failure: results from TREAT HF

MURAT S., KAYA H., ÇAVUŞOĞLU Y.
HEART FAILURE 2016, European Journal of Heart Failure Abstracts Supplement, Florence, İtalya, 21 - 24 Mayıs 2016, cilt.18, ss.93, (Özet Bildiri)

70. Potential clinical application of LCZ696 in patients with chronic heart failure in real life clinical practice: results from TREAT HF Study

ÇAVUŞOĞLU Y., MURAT S., KAYA H.
Heart failure 2016, European Heart Journal, Florence, İtalya, 21 - 24 Mayıs 2016, cilt.37, ss.204-2014, (Özet Bildiri)

71. Anemia and low haemoglobin levels are associated with worse functional status in patients with chronic heart failure: results from TREAT HF

MURAT S., KAYA H., ÇAVUŞOĞLU Y.
Heart failure 2016, European Journal of Heart Failure, Florence, İtalya, 21 - 24 Mayıs 2016, cilt.18, ss.217, (Özet Bildiri)

72. Serial changes and associated clinical variables of cardiac troponin release in patients with acute heart failure syndrome

ÇAVUŞOĞLU Y., GENCER E., MURAT S., MUTLU F., MORRAD B.
Heart failure 2016, European Journal of Heart Failure, Florence, İtalya, 21 - 24 Mayıs 2016, cilt.18, ss.100, (Özet Bildiri)

73. Alternative medicine and heart failure: should we focus on perception?

KAYA H., BETON O., YÜCEL H., MURAT S., YAĞMUR B., AÇAR B., et al.
31STTURKISH CARDIOLOGYCONGRESSWITH INTERNATIONAL PARTICIPATIONAccredited by, Antalya, Türkiye, 22 - 25 Ekim 2015, (Özet Bildiri)

74. Vaccination against flu is associated with better HF management

BETON O., KAYA H., YÜCEL H., MURAT S., YAĞMUR B., AÇAR B., et al.
31STTURKISH CARDIOLOGYCONGRESSWITH INTERNATIONAL PARTICIPATION, Antalya, Türkiye, 22 - 25 Ekim 2015, cilt.15, ss.32, (Özet Bildiri) Sürdürülebilir Kalkınma

75. Heart rate reduction with ivabradin in a case with nonischemicheart failure and LBBB who is candidate for CRT

ÇAVUŞOĞLU Y., BEKTAŞ M., MURAT S.
Heart failure 2015,European Journal of Heart Failure Abstracts Supplement, Sevilla, İspanya, 23 - 26 Mayıs 2015, cilt.17, ss.382, (Özet Bildiri)

76. Elevated cardiac troponin levels and related clinical variablesin acute decompensated heart failure

ÇAVUŞOĞLU Y., GENCER E., MERT K. U., NADİR A., MUTLU F., ERASLAN S., et al.
30th Turkish Cardiology Congresswith International Participation, Antalya, Türkiye, 23 - 26 Ekim 2014, cilt.14, ss.127, (Özet Bildiri)

77. Compared with dobutamine, levosimendan displaysa renoprotective potential in acute heart failure

ÇAVUŞOĞLU Y., GENCER E., MERT K. U., NADİR A., MUTLU F., MORRAD B., et al.
30th Turkish Cardiology Congresswith International Participation, Antalya, Türkiye, 23 - 26 Ekim 2014, cilt.14, ss.127, (Özet Bildiri)

78. Immunoadsorption therapy in patients with idiopathic dilated cardiomyopathy and refractory heartfailure who do not respond to optimal standard medical therapy: a report of two cases

ÇAVUŞOĞLU Y., tahmazov s., AKAY O. M., MURAT B., MURAT S., ULUS T.
Heart failure 2014, European Journal of Heart Failure Abstracts Supplement, atina, Yunanistan, 17 - 20 Mayıs 2014, cilt.16, ss.143, (Özet Bildiri)

79. Levosimendan shows potential renoprotective effect in addition to a better hemodynamic profile overdobutamine in patients presenting with acute heart failure syndromes

ÇAVUŞOĞLU Y., gencer e., MUTLU F., nadir a., MERT K. U., MURAT B., et al.
Heart failure 2014, European Journal of Heart Failure Abstracts Supplement ( 2014 ), atina, Yunanistan, 17 - 20 Mayıs 2014, cilt.16, ss.159, (Özet Bildiri)
Kitaplar 17

1. Preoperative Cardiovascular Assessment and Perioperative Management of Patients with Esophageal Cancer

MURAT B., MURAT S., GÜVENÇ T. S.
Risk Factors and Therapy of Esophagus Cancer, , Editör, Springer Nature, ss.263-291, 2024

2. Kalp yetersizliği

şener e., MURAT S.
Yoğun bakımda tanı ve tedavi, KARAKOÇ EBRU, YELKEN BİRGÜL, Editör, Akademisyen, ss.121-129, 2024

3. Ventriküler Aritmi Tedavisinde Perkütan Sol Sempatektomi.

Murat B., Murat S.
VENTRİKÜLER ARİTMİLER VE ANİ KARDİYAK ÖLÜM, Prof. Dr. Erkan BAYSAL Doç. Dr. Metin OKŞUL Uzm. Dr. Yusuf Ziya ŞENER, Editör, Akademisyen Kitabevi, Ankara, ss.683-689, 2023 Creative Commons License

4. Kalp Yetersizliğinde Diüretik Kullanımı

MURAT S., ÇAVUŞOĞLU Y.
DİÜRETİKLER VE KLİNİK KULLANIMLARI, Prof.Dr. Ahmet Uğur YALÇIN (Eskişehir Osmangazi Üniversitesi Tıp Fakültesi, Nefroloji BD, ESKİŞEHİR), Editör, Türkiye Klinikleri, ss.24-31, 2023

5. Sintigrafide çelişkili sonuçlar

Murat S., Çavuşoğlu Y., Ak Sivrikoz İ., Kocagil S., Yalvaç H. E., Gündüz E., et al.
Updates in Cardiology, Özpelit Ebru, Editör, AVES, İstanbul, ss.5-7, 2022 Creative Commons License

6. Maladaptif Miyokard ve Kalp Yetersizliği

MURAT S., DURAL M., ÇAVUŞOĞLU Y.
STRES ALTINDA KALP YAPISI: BİRLEŞİK ÇOKLU STRESİN SPESİFİK BULGUSU, yalçın, fatih, Editör, türkiye klinikleri, Ankara, ss.26-31, 2022

7. Akut Kalp Yetersizliğinde Volüm Durumu Değerlendirme

Murat S.
Tanıdan Tedaviye Kalp Yetersizliği, Ali Karagöz, Editör, Nobel Tıp Kitapevi, İstanbul, ss.129-138, 2021 Creative Commons License

8. Kemoterapi İlişkili Kardiyotoksisitenin Belirlenmesinde Kardiyak Biyobelirteçlerin Rolü

Murat S., Çavuşoğlu Y.
Kardiyoonkoloji - Kanser ve Kalp Hastalıkları - 2021, sibel çatırlı enar, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.16-24, 2021 Creative Commons License Sürdürülebilir Kalkınma

9. kardiyolog gözüyle diyabetik retinopatiye yaklaşım

Murat S.
diyabetik retinopatiye multidisipliner yaklaşım, Adnan Batman,Erdoğan Yaşar,Mustafa Değer Bilgiç, Editör, akademisyen , Ankara, ss.149-156, 2021 Creative Commons License Sürdürülebilir Kalkınma

10. kardiyolog gözüyle diyabetik retinopatiye yaklaşım

MURAT S.
diyabetik retinopatiye multidisipliner yaklaşım, adnan batman, erdoğan yaşar, mustafa değer bilgiç, Editör, akademisyen yayın evi, ss.149-156, 2021 Sürdürülebilir Kalkınma

11. Akut Kalp Yetersizliğinde Volüm Durumu Değerlendirme

MURAT S.
Tanıdan Tedaviye Kalp Yetersizliği, ali karagöz, Editör, nobel tıp kitabevi, ss.129-138, 2021

12. Kemoterapi İlişkili Kardiyotoksisitenin Belirlenmesinde Kardiyak Biyobelirteçlerin Rolü

MURAT S., ÇAVUŞOĞLU Y.
Kardiyoonkoloji - Kanser ve Kalp Hastalıkları - 2021, sibel çatırlı enar, Editör, Türkiye Klinikleri Tıp Bilimleri Dergisi, ss.16-24, 2021

13. KARDİYAK ARİTMİLER

Murat S., Murat B.
Dahili Aciller, Emin Murat AKBAŞ,Can ÖZLÜ,Edhem ÜNVER,Fatih ÖZÇIÇEK,Levent DEMIRTAŞ,Hasan YAŞAR,Erdem ÇANKAYA,Faruk KARAKEÇİLİ,Paşa ULUĞ,Arif Onur EDEN,Pınar ÖZTÜRK, Editör, AKADEMİSYEN KİTABEVİ, Ankara, ss.51-69, 2020 Creative Commons License

14. Wolff Parkinson White Sendromu Olan Atriyal FibrilasyonGelişen Hastaya Yaklaşım

Murat S.
VAKALARLA KARDİYOLOJİ, Efe EDEM, Editör, AKADEMİSYEN KİTABEVİ, Ankara, ss.33-37, 2020 Creative Commons License

15. Konjenital Kalp Hastalıklarında Kardiyak Dışı CerrahideCerrahi Öncesi Değerlendirme

Murat S., Babayiğit E.
PreoperatifDeğerlendirmede İçHastalıkları Prensipleri, Efe EDEM,Emin Murat AKBAŞ,Levent DEMİRTAŞ,Ali Murat SEDEF,Erdem ÇANKAYA,Nedim ONGUN,Özlem KUDAŞ,Müjgan GÜRLER,Feride MARIM,Pınar AYVAT,Can ÖZLÜ, Editör, AKADEMİSYEN KİTABEVİ, Ankara, ss.515-525, 2020 Creative Commons License

16. Noncompaction KardiyomiyopatiNoncompaction Cardiomyopathy

Murat S.
KALP YETERSİZLİĞİNE YOL AÇANNADİR KARDİYOMİYOPATİLER:TANI VE TEDAVİ YAKLAŞIMLARI, YÜKSEL ÇAVUŞOĞLU, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.56-62, 2020 Creative Commons License

17. Akut İskemik İnmede Görüntüleme: Ekokardiografi

Murat S.
ACİL İNME YÖNETİMİ, Doç.Dr. Engin ÖZAKIN,Prof.Dr. Atilla Özcan ÖZDEMİR,Dr. Öğr. Üyesi Özlem AYKAÇ, Editör, ESOGÜ, Eskişehir, ss.103-133, 2020 Creative Commons License
Metrikler

Yayın

177

Yayın (WoS)

62

Yayın (Scopus)

69

Atıf (WoS)

166

H-İndeks (WoS)

6

Atıf (Scopus)

220

H-İndeks (Scopus)

7

Atıf (Scholar)

13

H-İndeks (Scholar)

2

Atıf (TrDizin)

8

H-İndeks (TrDizin)

2

Atıf (Diğer Toplam)

10

Proje

1

Açık Erişim

14
BM Sürdürülebilir Kalkınma Amaçları